Antimicrobial resistance, one of the world’s biggest killers, has reached an alarming tipping point.

Changing the way antibiotics are developed and accessed.

A public-health driven model to tackle AMR.

Our latest news and resources.

Protecting people from the rise and spread of drug-resistant infections.

Supporting efforts to ensure the right antibiotics are developed and reach the people who need them.

Press releases.

Filter by

DNDi Comms GARDP NNS Jipmer Pondi Sept2019 Shatabdi17
Neonatal sepsis
Press Release

Landmark clinical trial to transform treatment options for newborns with sepsis expands to Asia

Read more
Thumbnail MMV GARDP DNDi PR2026 (1)
Corporate
Partners

DNDi, GARDP, and MMV join forces to accelerate drug development for patients in greatest need

Read more
Design banner
Statement

A Policy Brief for Member States: Strengthening Global Health Architecture Reform

Read more
New York, NY, U.S.A. – Headquarters of the United Nations: United Nations is an intergovernmental organization that aims to maintain international peace and security.
Statement

Why the IPEA Matters Now: A Policy Brief for Member States

Read more
HERA 3 funding
Corporate
Partners

The European Commission invests in CARB-X and GARDP to ramp up global response to antimicrobial resistance

Read more
High throughput screening
Corporate
Partners

Antabio and GARDP join forces to identify potential next-generation antibiotics

Read more
AdobeStock
Statement

GARDP revives clinical research into apramycin as potential treatment for life-threatening ‘superbugs’

Read more
Time100Health
Statement

GARDP Executive Director named among TIME’s 100 most influential people in health

Read more
243px Flag of Brazil
Statement

Statement on Brazil’s draft National Action Plan for Antimicrobial Resistance

Read more